Clinical Trials on Moderate to Severe Papulopustular Rosacea in Norway
Total 21 results
-
Galderma R&DCompleted
-
Vyne Therapeutics Inc.Premier Research Group plcCompletedFacial Papulopustular RosaceaUnited States
-
Vyne Therapeutics Inc.CompletedPapulopustular RosaceaUnited States
-
Dong-A ST Co., Ltd.Meiji Seika Pharma Co., Ltd.CompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Norwegian Institute of Public HealthGöteborg University; University of Bergen; The Research Council of Norway; Sussex...Completed
-
Sunnaas Rehabilitation HospitalUniversity of BergenCompletedHemiplegia | Cerebral Stroke | Moderate to Severe Functional ImpairmentsNorway
-
TakedaNimbus Lakshmi, Inc.; Innovaderm Research Inc.CompletedModerate to Severe Plaque PsoriasisUnited States, Canada
-
Norwegian Institute of Public HealthGöteborg University; University of Bergen; University of Tromso; Sussex Partnership... and other collaboratorsRecruitingAnxiety | Mild to Moderate DepressionNorway
-
Novartis PharmaceuticalsCompletedModerate to Severe Palmoplantar PsoriasisBelgium, United States, Hungary, Russian Federation, Turkey, Australia, Israel, Netherlands, Portugal, Spain, United Kingdom, Norway, Slovakia, Canada, Finland
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
Fresenius Kabi SwissBioSim GmbHCompletedModerate to Severe Rheumatoid ArthritisBulgaria, United Kingdom, Hungary, Czechia, Poland, Germany
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
Galderma R&DRecruitingModerate-to-Severe Atopic DermatitisUnited States, Denmark, Hungary, Poland, Spain
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Belgium, Bulgaria, Estonia, France, Georgia, Germany, Hungary, Italy, Poland, Singapore
-
Ferring PharmaceuticalsCompletedMild-to-moderate Ulcerative ColitisPoland, Hungary, Italy, Czechia, Netherlands, Slovakia
-
Protagonist Therapeutics, Inc.CompletedUlcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic SevereUnited States, Austria, Bulgaria, Canada, Georgia, Germany, Hungary, Italy, Korea, Republic of, Poland, Russian Federation, Serbia, Ukraine
-
Eisai Inc.PfizerCompletedMild to Severe Alzheimer's DiseaseUnited States